(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 6


Fig. 6. BAPTA (AM form) prevents the acceleration of Ins(1,4,5)P3-mediated Ca2+ release and limits the rise in [Ca2+]c. Depolarization (–70 to +10 mV, 3 seconds) (B) activated ICa (C) and increased [Ca2+]c (A). At –70 mV (B), local photolysis of Ins(1,4,5)P3 [{uparrow}; concentrations producing maximum (red) or submaximum (blue) responses] increased [Ca2+]c (A). Prior (7 minutes) introduction of BAPTA AM (50 µM) to the bathing solution reduced the Ins(1,4,5)P3-evoked [Ca2+]c rise (A, unfilled bar) owing to increased cytoplasmic Ca2+ buffering, as revealed by the reduced [Ca2+]c rise for a similar Ca2+ influx (A,C). Note the smaller rise in measured [Ca2+]c (from the fluorescence measurements) for a given calculated [Ca2+]c increase (from the Ca2+ current) in BAPTA (D) compared with that of controls. Scaling the [Ca2+]c transients obtained in BAPTA so that the depolarization-evoked transients in the presence and absence of the chelator are of comparable size allowed a compensation for the increased buffer capacity of the cell to be made (E; left-hand panel). Application of the same scaling factor to the Ins(1,4,5)P3-evoked [Ca2+]c increases revealed that the Ins(1,4,5)P3-evoked [Ca2+]c transients were substantially reduced in the presence of the chelator (E; middle and right panels). Significantly, when the cytoplasmic Ca2+ buffer capacity had been increased (with BAPTA), the increase in velocity of the [Ca2+]c rise (d[Ca2+]c/dt) seen in control was substantially reduced (F). Thus the rate of Ca2+ release was largely constant rather than increased (F) during the release process in the presence of the chelator – that is, the velocity increase arose as a result of a Ca2+-dependent positive feedback acting at the cytoplasmic aspect of the Ins(1,4,5)P3R. BAPTA in its Ca2+-free form (BAPTACafree) might itself directly inhibit Ins(1,4,5)P3R (Richardson and Taylor, 1993). However, high concentrations of BAPTA are required – for example, increasing BAPTACafree from 90 µM to 9 mM reduced Ins(1,4,5)P3-mediated Ca2+ release by 8% (Bootman et al., 1995).